Literature DB >> 11349158

Prospective analysis of a fever evaluation algorithm after major gynecologic surgery.

A Schwandt1, S J Andrews, J Fanning.   

Abstract

OBJECTIVE: We performed a prospective trial to evaluate the feasibility, accuracy, and safety of a postoperative fever algorithm that is based on symptoms and physical examination in an attempt to decrease the random use of urine cultures, blood cultures, and chest radiographs. STUDY
DESIGN: Our fever algorithm consisted of assessing all febrile postoperative patients for signs and symptoms of infection. If none were present, no tests were ordered.
RESULTS: Twenty-eight of 105 consecutive patients (27%) had postoperative fever after major gynecologic surgery. Three of 28 febrile patients (11%) were evaluated with tests according to the algorithm. Two of 28 febrile patients (7%) were evaluated in violation of the algorithm. Four febrile patients (14%) had documented infections. Two patients had infections within the first 30 days after discharge. Compared with our previous retrospective review, significantly fewer febrile patients were evaluated with testing with a significantly increased yield of positive test results.
CONCLUSIONS: Our postoperative fever evaluation algorithm that is based on symptoms and physical examination is feasible, is safe, decreases random testing, and increases the yield of positive test results.

Entities:  

Mesh:

Year:  2001        PMID: 11349158     DOI: 10.1067/mob.2001.115227

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

Review 1.  Infection Prevention and Evaluation of Fever After Laparoscopic Hysterectomy.

Authors:  Mark P Lachiewicz; Laura J Moulton; Oluwatosin Jaiyeoba
Journal:  JSLS       Date:  2015 Jul-Sep       Impact factor: 2.172

2.  Postoperative fever after liver resection: Incidence, risk factors, and characteristics associated with febrile infectious complication.

Authors:  Hon-Fan Lai; Ivy Yenwen Chau; Hao-Jan Lei; Shu-Cheng Chou; Cheng-Yuan Hsia; Yi-Chu Kao; Gar-Yang Chau
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.